Nusano Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 133

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $115M

  • Investors
  • 5

Nusano General Information

Description

Developer of a current ion source and linear accelerator intended to remove the current limitations of radioisotope manufacturing for medical application and innovation. The company offers a broad range of diagnostic and therapeutic radioisotopes which are produced uranium-free, helping healthcare sector clients develop radiopharmaceuticals for personalized cancer therapies at comparatively lower costs.

Contact Information

Website
www.nusano.com
Formerly Known As
Alpha Source
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 28575 Livington Avenue
  • Valencia
  • Santa Clarita, CA 91355
  • United States
+1 (424)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 28575 Livington Avenue
  • Valencia
  • Santa Clarita, CA 91355
  • United States
+1 (424)

Nusano Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nusano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 01-Oct-2024 $115M Completed Generating Revenue
4. Later Stage VC (Series B) 03-Nov-2022 Completed Generating Revenue
3. Later Stage VC (Series B) 23-Sep-2021 Completed Generating Revenue
2. Later Stage VC (Series A) 24-Oct-2018 $41.5M $44.7M Completed Generating Revenue
1. Seed Round 06-Nov-2017 $3.19M $3.19M Completed Generating Revenue
To view Nusano’s complete valuation and funding history, request access »

Nusano Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B+
Series B
Series A 42,811,907 $0.000010 8% $0.97 $0.97 1x $0.97 30.77%
To view Nusano’s complete cap table history, request access »

Nusano Patents

Nusano Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9659736-B2 Particle beam isotope generator apparatus, system and method Active 15-May-2009
US-20150228438-A1 Particle beam isotope generator apparatus, system and method Active 15-May-2009
US-20100290575-A1 Particle beam isotope generator apparatus, system and method Inactive 15-May-2009
AU-2009346233-A1 Ecr particle beam source apparatus, system and method Active 15-May-2009
EP-2430637-A1 Ecr particle beam source apparatus, system and method Inactive 15-May-2009 G21C17/112
To view Nusano’s complete patent history, request access »

Nusano Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nusano Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wasatch Equity Partners PE/Buyout Minority
BrightEdge Impact Investing Minority
Casdin Capital Venture Capital Minority
Verily Life Sciences PE-Backed Company Minority
S32 Venture Capital Minority
To view Nusano’s complete investors history, request access »

Nusano FAQs

  • When was Nusano founded?

    Nusano was founded in 2016.

  • Where is Nusano headquartered?

    Nusano is headquartered in Santa Clarita, CA.

  • What is the size of Nusano?

    Nusano has 133 total employees.

  • What industry is Nusano in?

    Nusano’s primary industry is Diagnostic Equipment.

  • Is Nusano a private or public company?

    Nusano is a Private company.

  • What is Nusano’s current revenue?

    The current revenue for Nusano is .

  • How much funding has Nusano raised over time?

    Nusano has raised $218M.

  • Who are Nusano’s investors?

    Wasatch Equity Partners, BrightEdge, Casdin Capital, Verily Life Sciences, and S32 have invested in Nusano.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »